Table 1 Summary of commonly used pancreatic cancer cell lines.
From: A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma
Cell line | Ethnic | Age | Sex | Derived from site | Degree of differentiation | Xenograft formation | Report time |
|---|---|---|---|---|---|---|---|
MIA PaCa-2 | Caucasian | 65 | Male | Body and tail | Undifferentiated | Yes | 197714 |
AsPC-1 | Caucasian | 62 | Female | Ascites* | Moderately-differentiated | Yes | 198115 |
PANC-1 | Caucasian | 56 | Male | Head | Undifferentiated carcinoma | Yes | 197516 |
SW1990 | Caucasian | 56 | Male | Tail | Grade II adenocarcinomas | Yes | 198317 |
BxPC-3 | Caucasian | 61 | Female | Body | Moderately-well differentiated | Yes | 198618 |
